Lv51
870 积分 2024-04-18 加入
Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease
1天前
已完结
Shifts in pharma’s therapeutic area focus
2个月前
已完结
The Role of Siglec-15 in Tumor Immunity: Mechanisms and Therapy
2个月前
已完结
Immunochromatographic assay for rapid detection of SIGLEC15 to evaluate its therapeutic potential in cervical cancer
9个月前
已完结
皖公网安备34019202002308
